Post-transplantation lymphoproliferative disorder in pediatric patient

Paulo Manuel Pêgo Fernandes; Estela Azeka; Vicente Odoni; Jader Joel Machado Junqueira; Gabriella Paiva Bento; Vera Aiello; Miguel Barbero-Marcial

doi:10.1590/s0066-782x2006001700026

Post-transplantation lymphoproliferative disorder in pediatric patient

Arq Bras Cardiol. 2006 Oct;87(4):e108-11. doi: 10.1590/s0066-782x2006001700026.

[Article in English, Portuguese]

Authors

Paulo Manuel Pêgo Fernandes¹, Estela Azeka, Vicente Odoni, Jader Joel Machado Junqueira, Gabriella Paiva Bento, Vera Aiello, Miguel Barbero-Marcial

Affiliation

¹ Instituto do Coração, Hospital das Clínicas, FM, USP, São Paulo, SP, Brazil. [email protected]

PMID: 17128294
DOI: 10.1590/s0066-782x2006001700026

Abstract

Immunosuppressive therapy for transplanted patients exposes them to a high risk of developing posttransplantation lymphoproliferative disorders (PTLD). We report the case of a child undergoing heart transplantation at seven months of age who developed PTLD at nine years of age, diagnosed by resection of a pulmonary nodule.

Publication types

Case Reports

MeSH terms

Cardiomyopathy, Dilated / surgery
Child
Heart Transplantation / adverse effects*
Humans
Immunosuppressive Agents / therapeutic use*
Lymphoproliferative Disorders / diagnosis
Lymphoproliferative Disorders / drug therapy
Lymphoproliferative Disorders / etiology*
Male
Treatment Outcome

Substances

Immunosuppressive Agents